Track the Zydus Lifesciences Limited stock price and the full management transaction log of the company, a listed equity based in India. Shares trade on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Zydus Lifesciences Limited has published 79 reports. Market capitalisation: €891.2bn. The latest transaction was filed on 14 November 2025 (Purchase). Among the most active insiders: DEVAL DHIRAJBHAI SHAH. The full history is accessible without an account.
79
Insider Decl.
0
Thresholds
€278,512
6 ops.
Buy Volume
€112m
69 ops.
Sell Volume
10Σ signal
Buys €278,512€112m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 7,743 of 25,898 companies
61.5
score / 100
Value
44
Quality
79
FCF yld-0.5%
Earn yld4.4%
EV/EBITDA15.0x
ROE18%
Gross mgn73%
Net mgn19%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.